Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Lincoln Electric
LECO
$13.8B
| $47.4M | 0.02% |
190,355
-17,662
| -8% | -$4.72M |
|
427
Astera Labs
ALAB
$50B
| $47.4M | 0.02% |
433,165
+421,755
| +3,696% | +$60.1M |
|
428
Gulfport Energy Corp
GPOR
$2.83B
| $47.3M | 0.02% |
223,669
+9,095
| +4% | +$1.81M |
|
|
ALMS
429
Alumis Inc
ALMS
$3.57B
| $46.8M | 0.02% |
+2,124,408
| New | +$53.1M |
|
430
EyePoint Inc
EYPT
$1.02B
| $46.4M | 0.02% |
3,601,168
+663,439
| +23% | +$9.92M |
|
431
Aurora
AUR
$11.7B
| $46.3M | 0.02% |
11,243,080
+10,724,682
| +2,069% | +$47.4M |
|
432
Sabra Healthcare REIT
SBRA
$5.64B
| $45.9M | 0.02% |
2,389,003
-62,702
| -3% | -$1.24M |
|
433
Ball Corp
BALL
$17B
| $45.4M | 0.02% |
767,269
-174,180
| -19% | -$10.6M |
|
434
Itron
ITRI
$3.73B
| $45.1M | 0.02% |
503,546
-625
| -0.1% | -$60K |
|
435
Towne Bank
TOWN
$3.35B
| $44.3M | 0.02% |
1,314,373
+607,768
| +86% | +$21.1M |
|
436
Mid-America Apartment Communities
MAA
$15.6B
| $44.1M | 0.02% |
361,577
-315,779
| -47% | -$41.7M |
|
437
Federal Realty Investment Trust
FRT
$10.9B
| $43.9M | 0.02% |
413,167
+10,095
| +3% | +$1.06M |
|
438
Enpro
NPO
$7.05B
| $43.9M | 0.02% |
175,090
+20,187
| +13% | +$5.05M |
|
439
Immix Biopharma
IMMX
$607M
| $43.7M | 0.02% |
4,802,002
+880,434
| +22% | +$6.47M |
|
440
Arcutis Biotherapeutics
ARQT
$3.42B
| $43.7M | 0.02% |
1,854,566
+24,505
| +1% | +$625K |
|
|
JBIO
441
Jade Biosciences
JBIO
$1.22B
| $43.6M | 0.02% |
+3,105,669
| New | +$45M |
|
|
EXE
442
Expand Energy Corp
EXE
$21.9B
| $43M | 0.02% |
391,303
-101,455
| -21% | -$10.8M |
|
443
Invivyd
IVVD
$180M
| $42.9M | 0.02% |
33,094,330
+551,188
| +2% | +$1.01M |
|
444
ACM Research
ACMR
$5.83B
| $42.7M | 0.02% |
1,085,634
+2,652
| +0.2% | +$141K |
|
445
Qorvo
QRVO
$7.63B
| $42.5M | 0.02% |
548,859
+88,070
| +19% | +$7.13M |
|
446
STAG Industrial
STAG
$7.86B
| $41.2M | 0.02% |
1,142,633
-29,658
| -3% | -$1.12M |
|
|
PPL
447
PPL Corp
PPL
$27.3B
| $40.3M | 0.02% |
1,053,937
+25,311
| +2% | +$934K |
|
448
Macerich
MAC
$7.32B
| $40M | 0.02% |
2,114,016
-137,947
| -6% | -$2.61M |
|
449
Kontoor Brands
KTB
$4.62B
| $39.7M | 0.02% |
564,955
+143,749
| +34% | +$9.41M |
|
450
Terreno Realty
TRNO
$7.68B
| $39.5M | 0.02% |
642,749
+595,225
| +1,252% | +$37.4M |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.